What rate should D5W (Dextrose 5% in Water) be administered at for a patient with hypernatremia (elevated sodium level of 154)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

D5W Administration Rate for Hypernatremia (Sodium 154 mEq/L)

For a patient with a sodium level of 154 mEq/L, D5W should be administered at a rate calculated to correct the free water deficit over 48 hours, typically resulting in an infusion rate of approximately 75-150 mL/hour for most adults, with the goal of reducing sodium by no more than 8-10 mEq/L per 24 hours. 1, 2

Calculation Method

Calculate the free water deficit using the formula: Water deficit = Total body water × [(Current Na⁺/Desired Na⁺) - 1], where Total body water = 0.6 × weight in kg for adult males (0.5 × weight for females). 2

For example, in a 70 kg male patient:

  • Total body water = 0.6 × 70 kg = 42 liters
  • Water deficit = 42 × [(154/145) - 1] = 42 × 0.062 = 2.6 liters
  • Rate over 48 hours = 2600 mL ÷ 48 hours = 54 mL/hour 2

Critical Correction Rate Guidelines

The maximum safe correction rate is 8-10 mEq/L per 24 hours, which translates to approximately 0.3-0.4 mEq/L per hour. 1, 2 The induced change in serum osmolality must not exceed 3 mOsm/kg H₂O per hour to prevent cerebral edema. 1, 2

More aggressive correction (>0.5 mEq/L per hour) has not been associated with increased mortality or neurologic complications in critically ill adults, but conservative rates remain the standard of care. 3, 4

Why D5W is the Correct Fluid Choice

D5W delivers pure free water because the dextrose is rapidly metabolized upon infusion, leaving only water behind with effectively zero tonicity after metabolism. 1 This provides no renal osmotic load, which is critical for controlled correction without adding sodium burden. 1

Normal saline (0.9% NaCl) must be avoided as it contains 154 mEq/L of sodium with an osmolarity of 308 mOsm/L, which would worsen hypernatremia rather than correct it. 1 Salt-containing solutions paradoxically exacerbate hypernatremia by providing excessive osmotic load that exceeds the patient's ability to excrete it. 1

Monitoring Protocol

  • Check serum sodium every 4-6 hours during initial correction to ensure the rate does not exceed safe limits 2
  • Adjust D5W rate based on sodium measurements to maintain correction within 8-10 mEq/L per 24 hours 2
  • Monitor for signs of fluid overload through hemodynamic assessment, input/output measurements, and clinical examination 2
  • Continue monitoring until osmolality normalizes to <300 mOsm/kg 2

Concurrent Electrolyte Management

Once adequate renal function and urine output are confirmed (≥0.5 mL/kg/hour), add 20-30 mEq/L potassium to D5W (using 2/3 KCl and 1/3 KPO4) as hypernatremia often coexists with potassium depletion. 1, 2 Verify serum potassium is <5.5 mEq/L before adding potassium to avoid life-threatening hyperkalemia. 1

Special Clinical Scenarios

In hyperglycemic crises (DKA/HHS) with hypernatremia, switch to D5W with appropriate electrolytes once glucose reaches 250-300 mg/dL to prevent worsening hypernatremia while continuing necessary electrolyte replacement. 5, 1

For patients with nephrogenic diabetes insipidus and hypernatremic dehydration, D5W is mandatory because these patients cannot concentrate urine and will worsen with isotonic fluids. 1

Common Pitfalls to Avoid

  • Never use isotonic saline (0.9% NaCl) as primary fluid for hypernatremia correction - it will worsen the condition 1
  • Do not correct too rapidly - exceeding 0.5 mEq/L per hour or 12 mEq/L per 24 hours risks cerebral edema 1, 2
  • Do not administer potassium without verifying adequate urine output first to prevent hyperkalemia 1
  • Avoid lactated Ringer's solution (sodium 130 mEq/L, osmolarity 273 mOsm/L) as it is hypotonic and not appropriate for hypernatremia correction 6

References

Guideline

Hypernatremia Correction with D5W

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Calculating Water Deficit and D5W Requirements for Hypernatremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Rate of Correction of Hypernatremia and Health Outcomes in Critically Ill Patients.

Clinical journal of the American Society of Nephrology : CJASN, 2019

Research

Severe hypernatremia correction rate and mortality in hospitalized patients.

The American journal of the medical sciences, 2011

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Sodium Imbalance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the correct order for D5W administration in an adult patient with hypernatremia?
What rate of D5W (Dextrose 5% in Water) is needed to correct hypernatremia from 132 to 128 mmol/L in 6 hours?
What is the correction rate for severe hypernatremia (elevated sodium levels)?
What is the appropriate correction rate for hypernatremia using D5W?
What is the recommended rate of sodium correction in patients with hyponatremia (low sodium levels) or hypernatremia (high sodium levels)?
What treatment approach is recommended for a 58-year-old male with HIV, Hepatitis B, and Hepatitis C presenting with pruritus and xerosis?
What is the best course of treatment for a patient with a history of COPD (Chronic Obstructive Pulmonary Disease) or asthma who has been exposed to carbon monoxide?
Is Fluimucyl (acetylcysteine) safe for a breastfeeding mother to use?
What is the appropriate initial evaluation and treatment approach for a patient presenting with lower abdominal pain, considering factors such as age, sex, medical history, and laboratory results?
What is the interpretation of a spinal fluid report with mild hyperproteinemia, elevated WBC count, and normal glucose level in a patient with a likely neurological condition?
Are there any significant interactions between the patient's current medications, including Ozempic (semaglutide), lamotrigine, escitalopram, Maxalt (rizatriptan) PRN, and melatonin, and the Maxalt (rizatriptan) wafers used to manage migraines in a patient with a history of type 2 diabetes, depression, anxiety, and migraines?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.